“Role of Natalizumab in Relapsing-Remitting Multiple Sclerosis: A Review”. Journal of Brain and Spine Foundation Nepal, vol. 2, no. 1, Aug. 2021, pp. 2-12, https://doi.org/10.3126/jbsfn.v2i1.39000.